Broyhill Asset Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.34M Sell
137,903
-20,311
-13% -$640K 4.01% 5
2025
Q4
$4.66M Buy
158,214
+39,759
+34% +$1.1M 4.11% 5
2025
Q3
$2.99M Buy
118,455
+29,714
+33% +$724K 2.62% 12
2025
Q2
$2.13M Sell
88,741
-22,964
-21% -$532K 1.94% 20
2025
Q1
$2.56M Buy
111,705
+1,230
+1% +$29.7K 2.08% 17
2024
Q4
$2.8M Buy
+110,475
New +$2.8M 2.46% 14

Other funds holding RTO

Broyhill Asset Management's RTO Position: Q1 2026 in Review

Broyhill Asset Management reduced its Rentokil (RTO) stake by 13% in Q1 2026, selling an estimated $640K and leaving 137,903 shares worth $4.34M. The position accounts for 4.01% of the portfolio, ranked #5.

Broyhill Asset Management first reported a position in RTO in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.66M in Q4 2025. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Broyhill Asset Management held 137,903 shares of Rentokil worth $4.34M as of Q1 2026.
  • Broyhill Asset Management sold 20,311 Rentokil shares in Q1 2026, an estimated $640K.
  • Rentokil made up 4.01% of Broyhill Asset Management's portfolio in Q1 2026, its #5 holding.
  • Broyhill Asset Management first reported a position in Rentokil in Q4 2024 and has held it in 6 quarters since.
  • Broyhill Asset Management's Rentokil position peaked at $4.66M in Q4 2025.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Broyhill Asset Management's 13F filing for Q1 2026, filed 6 May 2026.